|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stibine | CAS 7803-52-3 | ||
| SbH3 | RTECS WJ0700000 | ||
|
Synonyms & Trade Names Antimony hydride, Antimony trihydride, Hydrogen antimonide |
DOT ID & Guide 2676 119 |
||
|
Exposure Limits |
NIOSH REL: TWA 0.1 ppm (0.5 mg/m3) | ||
| OSHA PEL: TWA 0.1 ppm (0.5 mg/m3) | |||
| IDLH 5 ppm | Conversion 1 ppm = 5.10 mg/m3 | ||
|
Physical Description Colorless gas with a disagreeable odor like hydrogen sulfide. |
|||
|
MW: 124.8 |
BP: -1°F |
FRZ: -126°F |
Sol: Slight |
|
VP: >1 atm |
IP: 9.51 eV |
RGasD: 4.31 |
|
|
Fl.P: NA (Gas) |
UEL: ? |
LEL: ? |
|
| Flammable Gas | |||
|
Incompatibilities & Reactivities Acids, halogenated hydrocarbons, oxidizers, moisture, chlorine, ozone, ammonia |
|||
|
Measurement Methods NIOSH 6008 |
|
Personal Protection & Sanitation Skin: No recommendation Eyes: No recommendation Wash skin: No recommendation Remove: No recommendation Change: No recommendation |
First Aid (See procedures) Breathing: Respiratory support |
|
Respirator Recommendations
NIOSH/OSHA Up to 1 ppm: (APF = 10) Any supplied-air respirator Up to 2.5 ppm: (APF = 25) Any supplied-air respirator operated in a continuous-flow mode Up to 5 ppm: (APF = 50) Any supplied-air respirator that has a tight-fitting facepiece and is operated in a continuous-flow mode/(APF = 50) Any self-contained breathing apparatus with a full facepiece/(APF = 50) Any supplied-air respirator with a full facepiece Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted canister providing protection against the compound of concern/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation | |
| Symptoms Headache, lassitude (weakness, exhaustion); nausea, abdominal pain; lumbar pain, hematuria (blood in the urine), hemolytic anemia; jaundice; pulmonary irritation | |
|
Target Organs
Blood, liver, kidneys, respiratory system |
|
| See also: INTRODUCTION |